0001239819-20-000018.txt : 20200128 0001239819-20-000018.hdr.sgml : 20200128 20200127175827 ACCESSION NUMBER: 0001239819-20-000018 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200128 DATE AS OF CHANGE: 20200127 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Carilion Clinic CENTRAL INDEX KEY: 0001363589 IRS NUMBER: 541190771 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-89784 FILM NUMBER: 20550891 BUSINESS ADDRESS: STREET 1: EDWARD MURPHY, M.D. STREET 2: 213 SOUTH JEFFERSON STREET, SUITE 807 CITY: ROANOKE STATE: VA ZIP: 24011 BUSINESS PHONE: 540-981-7893 MAIL ADDRESS: STREET 1: EDWARD MURPHY, M.D. STREET 2: 213 SOUTH JEFFERSON STREET, SUITE 807 CITY: ROANOKE STATE: VA ZIP: 24011 FORMER COMPANY: FORMER CONFORMED NAME: Carilion Health System DATE OF NAME CHANGE: 20060519 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: LUNA INNOVATIONS INC CENTRAL INDEX KEY: 0001239819 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 301 FIRST STREET SW STREET 2: SUITE 200 CITY: ROANOKE STATE: VA ZIP: 24011 BUSINESS PHONE: 540-769-8400 MAIL ADDRESS: STREET 1: 301 FIRST STREET SW STREET 2: SUITE 200 CITY: ROANOKE STATE: VA ZIP: 24011 SC 13G 1 luna-13gforcarilion2020.htm SC 13G CARILION Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 13)*
LUNA INNOVATIONS INCORPORATED
(Name of Issuer)
COMMON STOCK
(Title of Class of Securities)
550351100
(CUSIP Number)
DECEMBER 31, 2019
(Date of Event Which Requires Filing of This Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
¨ Rule 13d-1(b)
¨ Rule 13d-1(c)
x Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Page 1 of 5



 



CUSIP No. 55035110
 
 
1.
Name of Reporting Persons
Carilion Clinic
2.
Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
(b)
3.
SEC USE ONLY
4.
Citizenship or Place of Organization

Virginia
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:
5.
Sole Voting Power

1,656,298
6.
Shared Voting Power

0
7.
Sole Dispositive Power

1,656,298
8.
Shared Dispositive Power

0
9.
Aggregate Amount Beneficially Owned by Each Reporting Person

1,656,298
10.
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
11.
Percent of Class Represented by Amount in Row (9)

5.5%1
12.
Type of Reporting Person (See Instructions)

CO
 
1 This percentage is calculated based upon 30,149,105 shares of the Issuer’s common stock outstanding as of December 31, 2019, as provided to the reporting person by the Issuer.





Page 2 of 5


Item 1.

(a)
Name of Issuer
Luna Innovations Incorporated

(b)
Address of Issuer’s Principal Executive Offices
301 First Street, SW, Suite 200
Roanoke, VA 24011
Item 2.    
(a)
Name of Person Filing
Carilion Clinic
            
(b)
Address of Principal Business Office or, if none, Residence

Carilion Roanoke Memorial Hospital
1906 Belleview Avenue
Roanoke, VA 24014
(c)
Citizenship
Virginia

(d)
Title of Class of Securities
Common Stock

(e)
CUSIP Number
550351100
Item 3.
If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable.
Item 4.
Ownership
(a)
Amount Beneficially Owned: 1,656,298
(b)
Percent of Class: 5.5%
(c)
Number of shares as to which the person has:
(i)
Sole power to vote or to direct the vote: 1,656,298
(ii)
Shared power to vote or to direct the vote: 0
(iii)
Sole power to dispose or to direct the disposition of: 1,656,298
(iv)
Shared power to dispose or to direct the disposition of: 0

Item 5.
Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following x.
Item 6.
Ownership of More than Five Percent on Behalf of Another Person

Page 3 of 5


Not applicable.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
Not applicable.
Item 8.
Identification and Classification of Members of the Group
Not applicable.
Item 9.
Notice of Dissolution of a Group
Not applicable.
Item 10.
Certification
Not applicable.

Page 4 of 5


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: January 27, 2020


CARILION CLINIC

By: /s/ G. Robert Vaughan, Jr.
   Name: G. Robert Vaughan, Jr.
   Title: Treasurer

 




Page 5 of 5